Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.019 AUD | +5.56% | -13.64% | -45.71% |
May. 22 | Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4% | MT |
May. 20 | Chimeric Therapeutics Receives Ethics Approval for CHM CDH17 Phase 1/2 Clinical Trial | MT |
- Stock Market
- Equities
- CHM Stock
- News Chimeric Therapeutics Limited
- Press Releases